聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 3 分钟 8 秒 前

Third Rock Ventures and The Column Group Launch Nurix with $25.1 Million Financing to Target Key Regulatory Pathway

周四, 05/22/2014 - 13:09
Company Brings Together Leaders in Ubiquitin-Proteasome Research to Discover and Develop Small Molecules with Broad Therapeutic Potential SAN FRANCISCO & BOSTON--(Healthcare Sales & Marketing Network)--Third Rock Ventures and The Column Group today anno...
Biopharmaceuticals, Venture Capital
Nurix, Third Rock Ventures, The Column Group, ubiquitin

Organizational Changes Strengthen and Expand Celgene Leadership Team

周四, 05/22/2014 - 13:01
SUMMIT, N.J.--(Healthcare Sales & Marketing Network)--Celgene Corporation (CELG) today announced organizational changes that will go into effect on August 1, 2014. Mark Alles is promoted to President and Chief Operating Officer (COO) Jacqualyn Fouse, P...
Biopharmaceuticals, Personnel
Celgene

Covidien Releases Two-Year Study Results Demonstrating Sustained Effectiveness of Drug-Coated Angioplasty Balloon Technology

周四, 05/22/2014 - 12:55
ILLUMENATE First-in-Human Clinical Trial Supports the Stellarex™ Balloon with EnduraCoat™ Technology in Treating Peripheral Arterial Disease PARIS--(Healthcare Sales & Marketing Network)--Covidien’s Stellarex™ drug-coated angioplasty balloon (Stellarex ...
Devices, Interventional
Covidien, Stellarex DCB, peripheral arterial disease, paclitaxel

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

周四, 05/22/2014 - 12:48
Results from the EnligHTN I, II and III trials presented during EuroPCR add to the growing body of clinical evidence supporting the benefits of EnligHTN renal denervation technologies ST. PAUL, Minn. & PARIS--(Healthcare Sales & Marketing Network)--St. ...
Devices, Cardiology
St. Jude Medical, EnligHTN III study, EnligHTN , renal denervation

Primary Endpoint Data Presented on Performance and Safety of the JenaValve TAVI System

周四, 05/22/2014 - 12:38
Data on Real-World Patient Population Shows Excellent Clinical Results; New Cathlete Plus™ Delivery System Provides Improved Ease-of-Use, Outcomes WILMINGTON, Del. & MUNICH--(Healthcare Sales & Marketing Network)-- JenaValve Technology, Inc., a private...
Devices, Interventional Cardiology
JenaValve Technology, TAVI, JenaValve

Veloxis Receives Positive Opinion from CHMP for Envarsus(R) for Treatment of Both Kidney and Liver Transplant Patients

周四, 05/22/2014 - 12:34
HORSHOLM, Denmark, May 22, 2014 -- (Healthcare Sales & Marketing Network) -- Veloxis Pharmaceuticals A/S (VELO.CO) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive...
Biopharmaceuticals, Regulatory
Veloxis Pharmaceuticals, Envarsus, tacrolimus, organ rejection

Santhera Reports Positive Outcome for Catena(R)/Raxone(R) in Phase III DMD Trial Supported by Additional Respiratory Function Data

周四, 05/22/2014 - 12:26
LIESTAL, SWITZERLAND--(Healthcare Sales & Marketing Network) - Santhera Pharmaceuticals (SIX:SANN) today reported that the results of secondary respiratory function endpoints from the on-going analysis of the DELOS trial in Duchenne Muscular Dystrophy (DMD...
Biopharmaceuticals
Santhera Pharmaceuticals, Duchenne Muscular Dystrophy, Catena , Raxone

Baxter Provides U.S. Regulatory Update on HyQvia, Its Investigational Subcutaneous Treatment for Primary Immunodeficiency

周三, 05/21/2014 - 17:46
DEERFIELD, Ill. & SAN DIEGO--(Healthcare Sales & Marketing Network)--Baxter International Inc. (BAX) and Halozyme Therapeutics, Inc., (HALO) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (P...
Biopharmaceuticals, FDA
Baxter, Halozyme Therapeutics, HYQVIA, Immune Globulin

El Camino Hospital Installs Five Carestream DRX Imaging Systems to Perform Portable X-ray Exams at Two Campuses

周三, 05/21/2014 - 17:38
Carestream Systems and Specialized Software Equip Hospitals to Help Reduce Dose for Pediatric and Adult Patients ROCHESTER, N.Y.--(Healthcare Sales & Marketing Network)--El Camino Hospital installed three CARESTREAM DRX-Revolution Mobile X-ray Systems a...
Devices, Radiology
Carestream Health, CARESTREAM DRX, DRX-Revolution

ReliantHeart's HeartAssist5(R) Achieves European CE Mark, Which Includes True Flow Remote Monitoring

周三, 05/21/2014 - 17:28
HOUSTON, TX--(Healthcare Sales & Marketing Network) - The ReliantHeart HeartAssist5® Ventricular Assist Device (VAD) has attained CE Mark approval for design enhancements. The CE Mark which includes remote monitoring via vadlink.com provides remote and...
Devices, Cardiology, Regulatory
ReliantHeart, HeartAssist5, Ventricular Assist Device

Lombard Medical Expands U.S. Sales Team

周三, 05/21/2014 - 17:22
Doubles number of U.S. Sales Representatives to 34 LONDON--(Healthcare Sales & Marketing Network)--Lombard Medical, Inc (EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), today announced th...
Devices, Interventional
Lombard Medical, Endovascular Aortic Repair, AAA, Aorfix , stent graft

Provectus Biopharmaceuticals Inc. Appoints Jacob M. Plotsker to Strategic Advisory Board

周三, 05/21/2014 - 17:16
PLOTSKER BRINGS PHARMA, BREAST CANCER EXPERTISE TO PROVECTUS Tenn.--(Healthcare Sales & Marketing Network)--Provectus Biopharmaceuticals, Inc. (PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announce...
Biopharmaceuticals, Personnel
Provectus Biopharmaceuticals

Clarus Therapeutics Appoints Patrick Shea Chief Commercial Officer

周三, 05/21/2014 - 14:53
Company Adds Pharmaceutical Veteran With Nearly 30 Year Sales and Marketing Track Record NORTHBROOK, Ill., May 21, 2014 -- (Healthcare Sales & Marketing Network) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on th...
Biopharmaceuticals, Personnel
Clarus Therapeutics, REXTORO, testosterone

Boston Scientific Reports Strong Performance Data For SYNERGY(TM) Stent System

周三, 05/21/2014 - 14:50
EVOLVE Study Data Presented Today at EuroPCR 2014 Also Demonstrate Excellent Safety Profile NATICK, Mass., May 21, 2014 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) reported positive three-year follow-up data for the...
Devices, Interventional Cardiology
Boston Scientific, SYNERGY Stent, drug eluting stent, coronary stent

Proa(R) Medical Receives 510(k) Clearance from FDA for Brella-Spec(TM) Vaginal Speculum for Gynecological and Obstetrical Procedures

周二, 05/20/2014 - 15:09
LOS ANGELES--(Healthcare Sales & Marketing Network)--Proa® Medical, Inc., developer of innovative and practical medical devices for women’s health, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market ...
Devices, FDA
Proa Medical, Brella-Spec, Vaginal Speculum

InspireMD to Showcase Embolic Systems with MicroNet(TM) Technology and Results from MASTER I Trial at EuroPCR Conference

周二, 05/20/2014 - 15:07
Company to Present at European Symposium Titled MGuard™ Embolic Protection Stent: The Importance of Thrombus Management in STEMI Primary PCI BOSTON, May 20, 2014 -- (Healthcare Sales & Marketing Network) -- InspireMD, Inc. ("InspireMD" or the...
Devices, Interventional Cardiology
InspireMD, embolic protection, MicroNet

Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer

周二, 05/20/2014 - 15:04
Company assembles Scientific Advisory Board comprised of world-leaders in microbiology and the clinical development of anti-infectives to combat severe infections resulting from highly drug-resistant, gram-negative bacteria CAMBRIDGE, Mass.--(Healthcare...
Biopharmaceuticals, Personnel
Spero Therapeutics

Pharmacyclics appoints Gregory R. Wade to lead Business Development

周二, 05/20/2014 - 14:59
SUNNYVALE, Calif., May 20, 2014 -- (Healthcare Sales & Marketing Network) -- Pharmacyclics, Inc. (the "Company") (PCYC) is pleased to announce that Gregory R. Wade has joined the company as Executive Vice President of Business Development. In hi...
Biopharmaceuticals, Personnel
Pharmacyclics

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients

周二, 05/20/2014 - 14:57
Final Results from APPOSITION IV Study Presented at EuroPCR: No late loss and perfect strut coverage at 9-months Faster arterial healing compared to conventional drug-eluting stents PRINCETON, N.J. & PARIS--(Healthcare Sales & Marketing Network)--...
Devices, Interventional Cardiology
STENTYS, Self-Apposing Stent, coronary stent, drug eluting stent

Edwards Lifesciences, Medtronic Agree to Global Transcatheter Valve Litigation Settlement

周二, 05/20/2014 - 14:51
All Patent Litigation Between the Companies to Be Dismissed IRVINE, CA--(Healthcare Sales & Marketing Network) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced th...
Devices, Interventional Cardiology, Litigation
Edwards Lifesciences, Medtronic, transcatheter, heart valve

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong